Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
ABBV - AbbVie Inc.
Market Cap 263.55B P/E 35.15 EPS this Y -2.10% Ern Qtrly Grth -32.30%
Income 5.3B Forward P/E 13.52 EPS next Y 11.10% 50D Avg Chg 8.00%
Sales 55B PEG 2.89 EPS past 5Y 3.71% 200D Avg Chg -1.00%
Dividend 4.00% Price/Book 19.85 EPS next 5Y 6.26% 52W High Chg -11.00%
Recommedations 2.10 Quick Ratio 0.59 Shares Outstanding 1.77B 52W Low Chg 14.00%
Insider Own 0.10% ROA 7.94% Shares Float 1.76B Beta 0.62
Inst Own 73.39% ROE 54.26% Shares Shorted/Prior 17.79M/20.19M Price 149.38
Gross Margin 69.66% Profit Margin 9.71% Avg. Volume 5,937,400 Target Price 197.33
Oper. Margin 34.56% Earnings Date Oct 30 Volume 5,753,546 Change 0.57%
Healthcare | Drug Manufacturers - General | United States
About AbbVie Inc.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

AbbVie Inc. News
11/16/24 Why AbbVie’s (ABBV) Drug Setback Creates A Prime Buy-The-Dip Moment
11/15/24 Pharma Stock Roundup: AZN, BAYRY's Earnings, ABBV's Pipeline Setback
11/15/24 AbbVie Stock Falls 11% in a Month: Should You Buy the Dip?
11/15/24 Got $1,500 to Invest? AbbVie Just Proved the Bull Thesis for Its Stock
11/14/24 Robert Bruce's Strategic Moves in Q3 2024: Spotlight on AerCap Holdings NV
11/14/24 Syros Stock Plunges as Lead Cancer Study Fails to Meet Primary Goal
11/14/24 2 Dividend Stocks to Buy Hand Over Fist in November
11/14/24 AbbVie Awards 20 Individuals Living With Migraine To Support Career Aspirations
11/12/24 AbbVie's Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio
11/12/24 AbbVie Stock Declines as Schizophrenia Studies Fail, BMY Gains
11/12/24 AbbVie’s stock plummets over 12% after schizophrenia drug flops in Phase II trials
11/12/24 Some Investors May Be Willing To Look Past AbbVie's (NYSE:ABBV) Soft Earnings
11/12/24 Company News for Nov 12, 2024
11/12/24 What the NFL Draft Can Teach Investors About Big Pharma
11/11/24 Dow Closes Above 44,000 for First Time; S&P 500 Tops 6,000 as Tesla Soars
11/11/24 Dow Closes Above 44,000 for First Time; S&P 500 Tops 6,000
11/11/24 S&P 500 Gains and Losses Today: Index Closes Above 6,000 on Post-Election Rally
11/11/24 Bristol Rockets 11% As Investors Question AbbVie's $8.7 Billion 'Mistake'
11/11/24 AbbVie tumbles on drug test disappointment, Bristol-Myers gains
11/11/24 Why AbbVie Stock Was Getting Mashed on Monday
ABBV Chatroom

User Image BobbyOleary Posted - 4 minutes ago

$O $NFLX $ABBV $MU $AMAT Join our WhatsApp group for day traders and stay informed about market trends and opportunities! Whats-app group Link Here'.🙏👇

User Image DividendsAtValue Posted - 5 hours ago

@usiv I don't read charts well, so thank you for specifying the dollar amount the trend line is going to, and explaining in plain English to "wait for it.". Most chartist just post a chart, and think everyone else knows how to interpret what it means. So thank you for being so helpful. $ABBV is my second largest position.

User Image Finanz Posted - 6 hours ago

$ABBV https://www.insidermonkey.com/blog/why-abbvies-abbv-drug-setback-creates-a-prime-buy-the-dip-moment-1391693/

User Image DividendsAtValue Posted - 7 hours ago

@DumbNDumper Yup. $ABBV is my second largest position. If it goes low enough Iight even add!

User Image DumbNDumper Posted - 9 hours ago

$ABBV institutions sold this week. Gonna be an interesting next few days..

User Image FrnkTss Posted - 17 hours ago

$ABBV good pull back to watch here https://youtu.be/a7g9U8gwdIA

User Image usiv Posted - 17 hours ago

$ABBV that monthly trend line should hold ultimately..which is around 155..will wait for it

User Image MoneyAndAdderall Posted - 17 hours ago

$ABBV Wolfe Research initiated coverage of AbbVie (ABBV) with an Outperform rating and $205 price target The firm noted that AbbVie sounded “quite confident” on immuno-inflammation contracting for 2025 on its Q3 earnings call. With outperformance expected for the company’s core I&I business and the recent share pullback following emraclidine’s Phase 2 failure in Schizophrenia, the firm would argue the current valuation is an increasingly attractive entry point.https://www.nasdaq.com/articles/wolfe-starts-abbvie-outperform-says-valuation-attractive-entry-point

User Image Article_AI Posted - 20 hours ago

$ABBV Dividend King AbbVie Just Paid Investors: Here's How Much They Got https://www.stck.pro/news/ABBV/93257185/

User Image DividendsAtValue Posted - 23 hours ago

@BugHunti I'm not swapping, I'm a dividend investor buying more. The prices brought about by this decline is great. Long $ABBV $PFE

User Image DividendsAtValue Posted - 1 day ago

@aj_81 @mathgenius I'd add, but $ABBV is already over 13% of my portfolio, so I think I'll just watch it for now. I did add to $PFE, and have a few others I'll be adding too on declining days like this...

User Image MontanaT Posted - 1 day ago

$ABBV reseting like 2022

User Image DividendsAtValue Posted - 1 day ago

@mathgenius Panic? Are you kidding? I'm delighted (not at the appointment of RFK, at the opportunity). This will push prices down and allow us to buy at great discounts. $ABBV is my second largest position. I added to $PFE this afternoon. Long $ABBV $GILD $MNKD $PFE

User Image ST4Life Posted - 1 day ago

$ABBV So did the ABBV employee that lead Cerevel acquisition get a new higher position with a raise?

User Image mathgenius Posted - 1 day ago

$ABBV Trump’s asinine appointment of Rfk jr, will hurt healthcare. Industry will react a lobbyists will set congress straight . Do not panic

User Image ST4Life Posted - 1 day ago

$ABBV The only thing ABBV needs now are downgrades and this will be another 10% down.

User Image DumbNDumper Posted - 1 day ago

$ABBV missed my call by seconds 😆 oh well. Can't catch em all.

User Image Guntz Posted - 1 day ago

$ABBV wonder if dividend being paid out had anything to do with the drop too. Does it usual drop when it is paid out?

User Image scottybebs Posted - 1 day ago

$ABBV what an awful week - brighter days ahead

User Image Bogeymakr Posted - 1 day ago

$ABBV Need RFK to whip his d-ck out again ... clown show.

User Image fishinNbanjo Posted - 1 day ago

$ABBV if you voted for trump, this is what you get i guess

User Image kashmoney1000 Posted - 1 day ago

$ABBV buy buy buy

User Image DumbNDumper Posted - 1 day ago

$ABBV selling before close. Good job bears. Probably gonna keep dipping but I don't like holding over weekends.

User Image fishinNbanjo Posted - 1 day ago

$ABBV i don't even care anymore

User Image iLikeStonks21 Posted - 1 day ago

$ABBV GL took a few months to bounce back...this might take a couple months too. Stocks go down on elevators and up on stairs

User Image DS10 Posted - 1 day ago

$ABBV 🫣🤢🤢🤮🤮🤮

User Image DumbNDumper Posted - 1 day ago

$ABBV sheesh!!!

User Image DumbNDumper Posted - 1 day ago

$ABBV 12 little candles on that struggle just for it to dump in 3 candles. Sheesh. Just let this die already. It's over. 💩

User Image ST4Life Posted - 1 day ago

$ABBV Lost 40 points in 2 weeks, has to be ABBV record.

User Image DumbNDumper Posted - 1 day ago

$ABBV lol. R.I.P. to the guys who made those little teenie weenie green candles. 😂

Analyst Ratings
Piper Sandler Overweight Aug 23, 24
Morgan Stanley Overweight Aug 12, 24
Cantor Fitzgerald Overweight Aug 5, 24
Cantor Fitzgerald Overweight Jul 26, 24
Truist Securities Buy Jul 26, 24
Wells Fargo Overweight Jul 26, 24
Barclays Overweight Jul 26, 24
BMO Capital Outperform Jul 19, 24
Morgan Stanley Overweight Jul 11, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Donoghoe Nicholas EVP, CHIEF BUS/STRAT.. EVP, CHIEF BUS/STRAT OFFICER Dec 26 Sell 154.72 2,912 450,545 55,903 12/28/23
GONZALEZ RICHARD A CHAIRMAN OF THE BOAR.. CHAIRMAN OF THE BOARD AND CEO Jul 31 Sell 148.87 78,500 11,686,295 565,294 08/02/23
Sorg Elaine K. SVP, US COMMERCIAL O.. SVP, US COMMERCIAL OPERATIONS Apr 17 Sell 161.84 7,499 1,213,638 35,330 04/19/23
Sorg Elaine K. SVP, US COMMERCIAL O.. SVP, US COMMERCIAL OPERATIONS Feb 28 Sell 155 15,003 2,325,465 42,829 03/02/23
Sorg Elaine K. SVP, US COMMERCIAL O.. SVP, US COMMERCIAL OPERATIONS Feb 28 Option 93.5 15,003 1,402,780 57,832 03/02/23
Siatis Perry C EVP, GC AND SECRETAR.. EVP, GC AND SECRETARY Feb 28 Sell 153.22 12,135 1,859,325 10,377 03/02/23
Strom Carrie C SVP & PRES GLOBAL AL.. SVP & PRES GLOBAL ALLERG AESTH Feb 16 Sell 151.02 28,541 4,310,262 37,921 02/21/23
Strom Carrie C SVP & PRES GLOBAL AL.. SVP & PRES GLOBAL ALLERG AESTH Feb 16 Option 62.09 14,179 880,374 66,462 02/21/23
SALEKI-GERHARDT AZITA EVP, OPERATIONS EVP, OPERATIONS Feb 16 Option 51.42 25,000 1,285,500 258,208 02/21/23
SALEKI-GERHARDT AZITA EVP, OPERATIONS EVP, OPERATIONS Feb 16 Sell 149.59 25,000 3,739,750 233,208 02/21/23
Sorg Elaine K. SVP, US COMMERCIAL O.. SVP, US COMMERCIAL OPERATIONS Feb 16 Sell 151.02 15,321 2,313,777 62,679 02/21/23
Sorg Elaine K. SVP, US COMMERCIAL O.. SVP, US COMMERCIAL OPERATIONS Feb 16 Option 105.92 15,321 1,622,800 78,000 02/21/23
SEVERINO MICHAEL Vice Chairman Vice Chairman May 23 Option 104.59 79,801 8,346,387 231,904 05/25/22
SEVERINO MICHAEL Vice Chairman Vice Chairman May 23 Sell 151.16 79,801 12,062,719 152,103 05/25/22
Gosebruch Henry O EVP, Chief Strategy.. EVP, Chief Strategy Officer May 16 Option 54.86 83,960 4,606,046 125,583 05/20/22
Gosebruch Henry O EVP, Chief Strategy.. EVP, Chief Strategy Officer May 16 Sell 155 83,960 13,013,800 41,623 05/20/22
SEVERINO MICHAEL Vice Chairman Vice Chairman May 16 Option 78.23 200,000 15,646,000 252,103 05/18/22
SEVERINO MICHAEL Vice Chairman Vice Chairman May 16 Sell 154.58 200,000 30,916,000 152,103 05/18/22
SEVERINO MICHAEL Vice Chairman Vice Chairman May 06 Sell 151.2 300,000 45,360,000 152,103 05/10/22
SEVERINO MICHAEL Vice Chairman Vice Chairman May 06 Option 57.21 300,000 17,163,000 252,103 05/10/22
Stewart Jeffrey Ryan EVP, Chief Commercia.. EVP, Chief Commercial Officer Mar 24 Option 58.88 27,690 1,630,387 88,631 03/25/22
Stewart Jeffrey Ryan EVP, Chief Commercia.. EVP, Chief Commercial Officer Mar 24 Sell 159.2 27,690 4,408,248 60,941 03/25/22
Durkin Brian L VP, Controller VP, Controller Mar 09 Option 79.02 11,682 923,112 37,722 03/11/22
Durkin Brian L VP, Controller VP, Controller Mar 09 Sell 150 18,628 2,794,200 19,094 03/11/22
Gosebruch Henry O EVP, Chief Strategy.. EVP, Chief Strategy Officer Mar 01 Sell 148.12 25,000 3,703,000 16,623 03/02/22
Gosebruch Henry O EVP, Chief Strategy.. EVP, Chief Strategy Officer Feb 25 Sell 148.43 15,000 2,226,450 41,623 03/01/22
Michael Robert A. Vice Chairman Vice Chairman Feb 25 Sell 148.32 43,105 6,393,334 37,877 03/01/22
Strom Carrie C SVP & Pres Global Al.. SVP & Pres Global Allerg Aesth Feb 07 Sell 141.17 2,396 338,243 42,499 02/08/22
AUSTIN ROXANNE S Director Director Nov 02 Sell 116.42 71,844 8,364,078 49,284 11/04/21
Sorg Elaine K. SVP, US Commercial O.. SVP, US Commercial Operations Aug 25 Sell 120 13,080 1,569,600 11,595 08/25/21
Sorg Elaine K. SVP, US Commercial O.. SVP, US Commercial Operations Aug 25 Option 114.36 7,080 809,669 18,675 08/25/21
Sorg Elaine K. SVP, US Commercial O.. SVP, US Commercial Operations Feb 24 Option 86.26 20,195 1,742,021 52,946 02/24/21
Sorg Elaine K. SVP, US Commercial O.. SVP, US Commercial Operations Feb 24 Sell 105 20,195 2,120,475 32,751 02/24/21
RICHMOND TIMOTHY J. EVP, Chief HR Office.. EVP, Chief HR Officer Dec 01 Option 51.42 51,990 2,673,326 51,990 12/01/20
RICHMOND TIMOTHY J. EVP, Chief HR Office.. EVP, Chief HR Officer Dec 01 Sell 105 51,990 5,458,950 12/01/20
SALEKI-GERHARDT AZITA EVP, Operations EVP, Operations Nov 12 Option 24.21 4,800 116,208 118,667 11/12/20
SALEKI-GERHARDT AZITA EVP, Operations EVP, Operations Nov 12 Sell 93.61 4,800 449,328 113,867 11/12/20
GONZALEZ RICHARD A Chairman of the Boar.. Chairman of the Board and CEO Nov 12 Option 56.87 194,154 11,041,538 512,796 11/12/20
GONZALEZ RICHARD A Chairman of the Boar.. Chairman of the Board and CEO Nov 12 Sell 96.76 231,604 22,410,003 318,642 11/12/20